Modes of action of trichloroethylene for kidney tumorigenesis

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 225-240

  Lash, Lawrence H ^a   Parker, Jean C ^b   Scott, Cheryl Siegel ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cell proliferation; Cysteine conjugate lyase; Genotoxicity; Kidney; Oxidative stress; Peroxisome proliferation; Renal cancer; Trichloroethylene; (2u) globulin

Indexed keywords

ACYLTRANSFERASE; ALPHA 2 GLOBULIN; CALCIUM ION; CYTOCHROME P450; DNA; GLUTATHIONE DERIVATIVE; GLUTATHIONE TRANSFERASE; PROTEIN; S (1,2 DICHLOROVINYL)CYSTEINE; TRICHLOROETHYLENE;

ACUTE TOXICITY; ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CELL REGENERATION; CHRONIC TOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; FEMALE; GENE EXPRESSION; GENOTOXICITY; HUMAN; KIDNEY TUMOR; MALE; METABOLITE; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ANIMALIA;

EID: 0033945538     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2225     Document Type: Article

References (209)

1. Lash LH, Fisher JW, Lipscomp JC, Parker JC. Metabolism of trichloroethylene. Environ Health Perspect 108(suppl 2):177-200 (2000).
2. Garnick MB, Richie JP. Renal neoplasia. In: The Kidney, Fifth Edition (Brenner BM, ed). Philadelphia:W.B. Saunders Company, 1996;1959-1977.
3. Marshall FF, Stewart AK, Menck HR. The national cancer data base: report on kidney cancers. Cancer 80:2167-2174 (1997).
4. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK. SEER Cancer Statistics Review, 1973-1995, Bethesda, MD:National Cancer Institute, 1998.
5. ACS. Cancer Facts and Figures-1998. Atlanta:American Cancer Society, 1996.
6. ACS. Cancer Facts and Figures-1997. Atlanta:American Cancer Society, 1997.
7. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni JF Jr. Renal cancer. In: Cancer Epidemiology and Prevention, 2nd Ed. (Schottenfeld D, Fraumeni JF Jr, eds), New York:Oxford Press, 1996;1142-1155.
8. McLaughlin JK., Hrubec Z, Heineman EF, Blot WJ, Fraumeni JF Jr. Renal cancer and cigarette smoking in a 26-year follow-up of U.S. veterans. Public Health Rep 105:535-537 (1990).
9. McLaughlin JK, Gao YT, Gao RN, Zheng W, Ji BT, Blot WJ, Fraumeni JF Jr. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer 52:562-565 (1992).
10. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark. I: Role of socioeconomic status, tobacco use, beverages, end family history. Cancer Causes & Control 5:105-113 (1994).
11. McLaughlin JK, Lindblad P, Mellemgaard A, McCredie M, Mandel JS, Schlehofer B, Pommer W, Adami HO. International renal-cell cancer study. I: Tobacco use. Int J Cancer 60:194-198 (1995).
12. McLaughlin JK, Silverman DT, Hsing AK, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, Fraumeni JR Jr. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52:254-257 (1992).
13. McLaughlin JK. Kidney. In: Cancer Rates and Risks, 4th Ed. Bethesda, MD:National Cancer Institute, 1996;145-147.
14. Chow WH, McLaughlin JK, Linet MS, Niwa A, Mandel JS. Use of analgesics and risk of renal cell cancer. Int J Cancer 59:467-470 (1994).
15. Linet MS, Chow WH, McLaughlin JK, Wacholder S, Yu MC, Schoenberg JB, Lynch C, Fraumeni JF Jr. Analgesics and cancers of the renal pelvis and ureter. Int J Cancer 62:15-18 (1995).
16. McCredie M, Pommer W, McLaughlin JK, Steward JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B, Niwa S. International renal-cell cancer study. II: Analgesics. Int J Cancer 60:345-349 (1995).
17. IARC. An Updating of IARC Monographs, Vols 1 to 42. IARC Monographs on Eval Carcinog Risks, Suppl 7. Lyon:International Agency for Research on Cancer, 1987;310-312.
18. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomarkers Prev 4:327-331 (1995).
19. Finkle WD, McLaughlin JK, Rasgon SA, Yeoh HH, Low JE. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 4:555-558 (1993).
20. Lindblad P, McLaughlin JK, Mellemgaard A, Adami HO. Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study. Int J Cancer 55:5-9 (1993).
21. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, Schlehofer B, Pommer W, Niwa S, Adami HO. International renal-cell cancer study. VIII: Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63:216-221 (1995).
22. Mellemgaard A, Niwa S, Mehl ES, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23:923-930 (1994).
23. Chow WH, Gridley G, McLaughlin JK, Mandel JS, Wacholder S, Blot WJ, Niwa S, Fraumeni JF Jr. Protein intake and risk of renal cell cancer. J Natl Cancer Inst 86:1131-1139 (1994).
24. Wolk A, Gridley G, Niwa S, Lindblad P, McCredie M, Mellemgaard A, Mandel JS, Wahrendorf J, McLaughlin JK, Adami HO. International renal-cell cancer study. VII: Role of diet. Int J Cancer 65:67-73 (1996).
25. Mellemgaard A, Lindblad P, Schlehofer B, Bergstrom R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W. International renal-cell cancer study. III: Role of weight, height, physical activity, and use of amphetamines. Int J Cancer 60:350-354 (1995).
26. Chow WH, McLaughlin JK, Mandel JS, Blot WJ, Niwa S, Fraumeni JF Jr. Reproductive factors and the risk of renal cell cancer among women. Int J Cancer 60:321-324 (1995).
27. Lindblad P, Mellemgaard A, Schlehofer B, Adami HO, McCredie M, McLaughlin JK, Mandel JS. International renal-cell cancer study. V: Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61:192-198 (1995).
28. Mellemgaard A, Engholm G, McLaugnlin JK, Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III: Role of weight, physical activity and reproductive factors. Int J Cancer 56:66-71 (1994).
29. Mellemgaard A, Enghol G, McLaughlin JK, Olsen JH. Occupational risk factors for renal-cell carcinoma in Denmark. Scand J Work Environ Health 20:160-165 (1994).
30. McLaughlin JK. Renal cell cancer and exposure to gasoline: a review. Environ Health Perspect 101 (suppl 6):111-114 (1993).
31. Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, McCredie M, Adami HO. International renal-cell cancer study. IV. Occup Int J Cancer 61:601-605 (1995).
32. Partanen T, Heikkila P, Hernberg S, Kauppinen T, Moneta G, Ojajarvi A. Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health 17:231-239 (1991).
33. Siemiatycki J, Dewar R, Nadon L, Gerin M, Richardson L, Wacholder S. Associations between several sites of cancer and twelve petroleum-derived liquids. Scand J Work Environ Health 13:493-504 (1987).
34. Wong O, Raabe GK. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am J Ind Med 15:283-310 (1989).
35. Gamble JF, Pearlman ED, Nicolich MJ. A nested case-control study of kidney cancer among refinery/petrochemical workers. Environ Health Perspect 104:642-650 (1996).
36. Lynge E, Andersen A, Nilsoon R, Barlow L, Pukkala E, Norlinder R, Boffetta P, Grandjean P, Heikkila P, Horte LG, et al. Risk of cancer and exposure to gasoline vapors. Am J Epidemiol 145:449-458 (1997).
37. Rushton L. Further follow-up of mortality in a United Kingdom oil distribution centre cohort. Br J Ind Med 50:561-569 (1993).
38. Rushton L, Alderson MR. Epidemiological survey of oil distribution centres in Britain. Br J Ind Med 40:330-339 (1981).
39. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320 (1993).
40. Maher ER, Kaelin WG Jr. von Hippel-Lindau disease. Medicine 76:381-391 (1997).
41. Chauveau D, Duvic C, Chretien Y, Paraf F, Droz D, Melki P, Helenon O, Richard S, Grunfeld JP. Renal involvement in von Hippel-Lindau disease. Kidney Int 50:944-951 (1996).
42. Kinzler DW, Vogelstein B. Gatekeepers and caretakers. Nature 386:761-763 (1997).
43. Davis NJ, Wolman R, Milne FJ, van Niekerk I. Acute renal failure due to trichloroethylene poisoning. Br J Ind Med 46:347-349 (1989).
44. Nagaya T, Ishikawa N, Hata H. Urinary total protein and beta-2-microglobulin in workers exposed to trichloroethylene. Environ Res 50:86-92 (1989).
45. Rasmussen K, Brogren CH, Sabroe S. Subclinical effects on liver and kidney function and solvent exposure. Int Arch Occup Environ Health 64:445-448 (1993).
46. Selden A, Hultberg B, Ulander A, Ahlbord G Jr. Trichloroethylene exposure in vapor degreasing and the urinary excretion of N-acetyl-beta-D-glucosaminidase. Arch Toxicol 67:224-226 (1993).
47. Brüning T, Vamvakas S, Makropoulos V, Birner G. Acute intoxication with trichloroethylene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol Sci 41:157-165 (1998).
48. Brüning T, Sundberg AG, Birner G, Lammert M, Bolt HM, Appelkvist EL, Nilsson R, Dallner G. Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure. Arch Toxicol 73:246-254 (1999).
49. IARC. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 63: Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. Lyon:International Agency for Research on Cancer, 1995;75-158.
50. Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Med 37:797-806 (1995).
51. Axelsor O, Selden A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study of trichloroethylene and cancer risk. J Occup Med 36:556-562 (1994).
52. Spirtas R, Stewart P, Lee S. Retrospective cohort mortality study of worker at an aircraft maintenance facility. II: Exposures and the assessment. Br J Ind Med 48:531-537 (1991).
53. Henschler D, Vamvakas S, Lammert M, Dekant W, Kraus B, Thomas B, Ulm K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch Toxicol 69:291-299 (1995).
54. Bloemen LJ, Tomenson J. Increased incidence of renal cell tumors in a cohort of workers exposed to trichloroethylene [Letter to the Editor]. Arch Toxicol 70:129-130 (1995).
55. Henschler D, Vamvakas S, Lammert M, Dekant W, Kraus B, Thomas B, Ulm K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene [Reply]. Arch Toxicol 70:131-133 (1995).
56. Swaen GMH. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene [Letter to the Editor]. Arch Toxicol 70:127-128 (1995).
57. McLaughlin JK, Blot WJ. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int Arch Occup Environ Health 70:222-231 (1997).
58. Weiss NS. Cancer in relation to occupational exposure to trichloroethylene. Occup Environ Med 53:1-5 (1996).
59. Blair A, Hartge P, Stewart PA, McAdams M, Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med 55:161-171 (1998).
60. Morgan RW, Kelsh MA, Zhao K, Heringer S, Mortality of aerospace workers exposed to trichloroethylene. Epidemiology 9:424-431 (1998).
61. Vamvakas S, Brüning T, Thomasson B, Lammert M, Baumüller , Bolt HM, Dekant W, Birner G, Henschler D, Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethene. J Cancer Res Clin Oncology 124:374-382 (1998).
62. Wong O, Morgan R. Final Report: Historical Prospective Mortality Study of Hughes Aircraft Employees at Air Force Plant No. 44. Alameda, CA:ENSR Health Sciences, 1990.
63. Brüning T, Golka K, Makropoulos V, Bolt HM. Preexistence of chronic tubular damage in cases of renal cell cancer after long and high exposure to trichloroethylene. Arch Toxicol 70:259-260 (1996).
64. Brüning T, Weirich G, Hornauer MA, Hofler H, Brauch H. Renal cell carcinomas in trichloroethylene (TRI) exposed persons associated with somatic mutations in the von Hippel-Lindau (VHL) tumor suppressor gene. Arch Toxicol 71:332-335 (1997).
65. Brüning T, Lammert M, Kempkes M, Their R, Golka K, Bolt HM. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol 71:596-599 (1997).
66. Brüning T, Weirich G, Belt HM, Brauch H. Dose-dependent mutagenicity at the von Hippel-Lindau (VHL) tumor suppressor gene in renal cell cancer (RCC) patients exposed to trichloroethylene (TRI) [Abstract]. Toxicologist/Toxicol Sci 42:238 (1998).
67. Brüning T. Personal communication.
68. Henschler D, Romen W, Elsasser HM, Reichert D, Eder E, Radwan Z. Carcinogenicity studies of trichloroethylene by longterm inhalation in three animal species. Arch Toxicol 43:237-248.
69. Maltoni C, Lefemine G, Cotti G, Perino G. Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice. Ann NY Acad Sci 534:316-342 (1988).
70. NCI. Carcinogeriesis Bioassay of Trichloroethylene. Carcinogenesis Technical Rpt Ser 2. NIH Publ no 76-802. Bethesda, MD:National Cancer Institute, 1976.
71. NTP. Carcinogenesis Bioassay of Trichloroethylene. NIH Publ no 82-1799. Bethesda, MD:National Toxicology Program, 1982.
72. NTP. Toxicology and Carcinogenesis Studies of Trichloroethylene (CAS No. 79-01-6) in Four Strains of Rat (ACI, August, Marshall, and Osborne-Mendel) (Gavage Studies). NTP-TR-273. Research Triangle Park, NC:National Toxicology Program, 1988.
73. 1 Mice (Gavage Study). NTP TR 243. Research Triangle Park, NC: National Toxicology Program, 1990.
74. U.S. EPA. Health Assessment Document for Trichloroethylene. Final Report. Office of Health and Environmental Assessment. EPA/600/8-82/006F. Washington, DC:U.S. Environmental Protection Agency, 1985.
75. U.S. EPA. Update to the Health Assessment Document for Trichloroethylene: Updated Carcinogenicity Assessment for Trichloroethylene. External Review Draft. EPA/600/8-82/006FA. Washington, DC:U.S. Environmental Protection Agency, 1987.
76. Goeptar AR, Commandeur JNM, van Ommen B, van Bladeren PJ, Vermeulen NPE. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem Res Toxicol 83-21 (1995).
77. Lash LH. Role of renal metabolism in risk to toxic chemicals. Environ Health Perspect 102:75-79 (1994).
78. Lash LH. The role of metabolism in chemically-induced nephrotoxicity. In: Mechanisms of Injury in Renal Disease and Toxicity (Goldstein RS, ed). Boca Raton, FL:CRC Press, 1994;207-234.
79. Kim H, Kim SG, Lee M-Y, Novak RF. Evidence for elevation of cytochrone P4502E1 (alcohol-inducible form) mRNA levels in rat kidney following pyridine administrat on Biochem Biophys Res Commun 186:846-853 (1992).
80. Wu D, Cederbaum AI. Characterization of pyrazole and 4-methylpyrazole induction of cytochrorne P4502E1 in rat kidney. J Pharmacol Exp Ther 270:407-413 (1994).
81. Lash LH, Xu Y, Elfarra AA, Duescher RJ, Parker JC. Glutathione-dependent metabolism of trichloroethylene in isolated liver end kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab Dispos 23:846-853 (1995).
82. Lash LH, Qian W, Putt DA, Jacobs K, Elfarra AA, Krause RJ, Parker JC. Glutathione conjugation of trichloroethylene in rats and mice: Sex-, species-, and tissue-dependent differences. Drug Metab Dispos 26:12-19 (1998).
83. Varkonyi P, Gallo JM, Srivatsan V, Muralidhara S, Dallas CE, Bruckner JV. Unpublished data.
84. Green T, Dow J, Foster JR, Hext PM. Formic acid excretion in rats dosed with trichloroethylene a possible explanation for long term kidney damage. Toxicology 127:39-47 (1998).
85. Bull RJ. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ Health Perspect 108(suppl 2):241-259 (2000).
86. Bruschi SA, Bull RJ. In vitro cytotoxicity of mono-, di-, and trichloroacetate and its modulation by hepatic peroxisome proliferation. Fundam Appl Toxicol 21:366-375 (1993).
87. Bull RJ, Templin M, Larson JL, Stevens DK. The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene. Toxicol Lett 68:203-211 (1993).
88. Goldsworthy TL, Popp JA. Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol Appl Pharmacol 88:225-233 (1987).
89. Odum J, Green T, Foster JR, Hext PM. The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat. Toxicol Appl Pharmacol 92:103-112 (1988).
90. De Craemer D, Vamecq J, Roels F, Vallee L, Pauwels M, van den Branden C. Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets. J Lipid Res 35:1241-1250 (1994).
91. van den Branden C, De Craemer D, Pauwels M, Vamecq J. Peroxisomes in mice fed a diet supplemented with low doses of fish oil. Lipids 30:701-705 (1995).
92. Cimini AM, Sulli A, Stefanini S, Serafini B, Moreno S, Rossi L, Giorgi M, Ceru MP. Effects of di-(2-ethylhexyl)phthalate on peroxisomes of liver, kidney and brain of lactating rats and their pups. Cell Mol Biol 40:1063-1076 (1994).
93. Sundseth SS, Waxman DJ. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J Biol Chem 267:3915-3921 (1992).
94. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 48:5316-5324 (1988).
95. Aersaether N, Aarsland A, Kryvi H, Nilsson A, Svardal A, Ueland PM, Berge RK. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: a biochemical and morphological investigation. Carcinogenesis 10:987-994 (1939).
96. Ponchaut S, Draye JP, Veitch K, van Hoof F. Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes. Biochem Pharmacol 41:1419-1428 (1991).
97. Kluwe WM. The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals. Regul Toxicol Pharmacol 20:170-186 (1994).
98. Lake BG. Peroxisome proliferation current mechanisms relating to non-genotoxic carcinogenesis. Toxicol Lett 82/83:673-681 (1995).
99. Lehman-McKeeman LD, Rivera-Torres MI, Caudili D. Lysosomal degradation of α2u-globulin and α2u-globulin-xenobiotic conjugates. Toxicol Appl Pharmacol 103:539-548 (1990).
100. Goldsworthy TL, Lyght D, Burnett VL, Popp JA. Potential role of α-2u-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylere, and pentachloroethane. Toxicol Appl Pharmacol 96:367-379 (1988).
101. Melnick RL. An alternative hypothesis on the role of chemically induced protein droplet (α2u-globulin) nephropathy in renal carcinogenesis. Regul Toxicol Pharmacol 16:111-125 (1992).
102. Borghoff SJ, Lehman-McKeeman LD, Short BG, Hard GC, Swenberg JA. Critique of R. Melnick's "An Alternative Hypothesis on the Role of Chemically Induced Protein Droplet (α2u-Globulin) Nephropathy in Renal Carcinogenesis." Regul Toxicol Pharmacol 18:357-364 (1993).
103. Melnick RL. Critique does not validate assumptons in the model on α2u-globulin and renal carcinogenesis. Regul Toxicol Pharmacol 18:365-368 (1993).
104. National Research Council. Biologic Markets in Urinary Toxicology. Chap 6. Washington:National Academy Press, 1995.
105. Flamm WG, Lehman-McKeeman LD. The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. Regul Toxicol Pharmacol 13:70-86 (1991).
106. Ashby J. α2u-Globulin nephropathy in white ravens [Letter]. Environ Health Perspect 104:1264 (1996).
107. Ashby J. The relevance of mechanistic data to the interpretation and extrapolation to humans of rodent carcinogenicity data [Letter]. Environ Health Perspect 105:902-903 (1997).
108. de la Iglesia FA, Gough AW, Sigler RE. α2u-Globulin nephropathy and ravens: Do ravens of a different feather flock together? [Letter]. Environ Health Perspect 105:903-904 (1997).
109. Dietrich DR. Doubting nongenotoxic mechanisms of renal cancer: comparing apples and oranges in the α2u-globulin hypothesis [Letter]. Environ Health Perspect 105:898-902 (1997).
110. Huff J. Mechanisms, chemical carcinogenesis, and risk assessment: cell proliferation and cancer. Am J Ind Med 27:293-300 (1995).
111. Huff J. Response: α2u-Globulin nephropathy, proposed mechanisms, and white ravens [Letter]. Environ Health Perspect 104:1264-1267 (1996).
112. Melnick RL, Kohn MC, Huff J. Weight of evidence versus weight of speculation to evaluate the α2u-globulin hypothesis. Environ Health Perspect 105:904-906 (1997).
113. Crebelli R, Bignami M, Conti L, Carere A. Mutagenicity of trichloroethylene in Salmonella typhimurium TA100. Ann 1st Super Sanita 18:117-122 (1982).
114. Simmon VF, Kauhanen K, Tardiff RG. Mutagenic activity of chemicals identified in drinking water. Prog Genet Toxicol 2:249-258 (1977).
115. Crebelli R, Conti G, Conti L, Carere A. Mutagenicity of trichloroethylene trichloroethanol and chloral hydrate in Asoergillus nidulan. Mutat Res 155:105-111 (1985).
116. White AE, Eger EI, Wolff S, Stevens WC. Sister chromatid exchange induced by inhaled anesthetics. Anesthesiology 50:426-430 (1979).
117. Shimada T, Swanson AF, Leber P, Williams GM. Activities of chlorinated ethane and ethylene compounds in the Salmonella/rat microsome mutagenesis and rat hepatocyte/ DNA repair assays under vapor phase exposure conditions. Cell Biol Toxicol 1:159-179 (1985).
118. Nagaya T, Ishikawa N, Hata H. Sister chromatid exchanges in lymphocytes of workers exposed to trichloroethylene. Mutat Res 222:279-282 (1989).
119. Dekant W, Vamvakas S, Berthold K, Schmidt S, Wild D, Henschler D. Bacterial β-lyase and the mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene. Chem-Biol Interact 60:31-45 (1985).
120. Vamvakas S, Elfarra AA, Dekant W, Henschler D, Anders MW. Mutagenicity of amino acid and glutathione S-conjugates in the Ames test. Mutat Res 206:83-90 (1988).
121. Commandeur JN, Boogaard PJ, Mulder GJ, Vermeulen NP. Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene. Arch Toxicol 65:373-380 (1991).
122. Vamvakas S, Dekant W, Schiffmann D, Henschler D. Incuction of unscheduled DNA synthesis and micronucleus formation in Syrian hamster embryo fibroblasts treated with cysteine S-conjugates of chlorinated hydrocarbons. Cell Biol Toxicol 4:393-403 (1988).
123. Vamvakas S, Dekant W, Herschler D. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes. Mutat Res 222:329-335 (1989).
124. 2+ and their association with cytotoxicity to renal cells. Biochem Pharmacol 44:1131-1138 (1992).
125. Green T, Odum J. Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro-and fluoroalkenes. Chem-Biol Interact 54:15-31 (1985).
126. Völkel W, Dekant W. Chlorothionetene, the ultimate reactive intermediate formed by cysteine conjugate β-lyase-mediated cleavage of the trichloroethene metabolite S-(1,2-dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem Res Toxicol 11:1082-1088 (1998).
127. Chakrabarti SK, Tuchweber B. Studies of acute nephrotoxic potential of trichloroethylene in Fischer 344 rats. J Toxicol Environ Health 23:147-158 (1988).
128. Cojocel C, Beuter W, Mullet W, Mayer D. Lipid peroxidation: a possible mechanism of trichloroethylene-induced nephrotoxicity. Toxicology 55:131-141 (1989).
129. Terracini B, Parker VH. A pathological study on the toxicity of S-d-chlorovinyl-L-cysteine. Food Cosmet Toxicol 3:67-74 (1965).
130. Jafte DR, Gandolfi AJ, Nagle RB. Chronic toxicity of S-(trans-1,2-dichlorovinyl)-L-cysteine in mice. J Appl Toxicol 4:315-319 (1984).
131. Elfarra AA, Jakobsor I, Anders MW. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem Pharmacol 35:283-288 (1986).
132. Darnerud PO, Brandt I, Feil VJ, Bakke JE. Dichlorovinyl cysteine (DCVC) in the mouse kidney tissue-binding and toxicity after glulathione depletion and probenecid treatment. Arch Toxicol 63:345-350 (1989).
133. 2 cells of the proximal tubule. Toxicology 69:151-164 (1991).
134. Wolfgang GH, Gandolfi AJ, Stevens JL, Brendel K. In vitro and n vivo nephrotoxicity of the L and D isomers of S-(1,2-dichlorovinyl)-cysteine. Toxicology 58:33-42 (1989).
135. Ilinskaja O, Vamvakas S. Alterations of the renal function in the solated perfused rat kidney system after in vivo and in vitro application of S-(1,2-dichlorovinyl)-L-cysteine and S-(2,2-dichlorovinyl)-L-cysteine. Arch Toxicol 70:224-229 (1996).
136. Dekant W, Martens G, Vamvakas S, Metzler M, Henschler D. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab Dispos 15:702-709 (1987).
137. Dekant W, Berthold K, Vamvakas S, Henschler D, Anders MW. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichorovinyl)-L-cysteine by cysleme conjugate β-lyase. Chem Res Toxicol 1:175-178 (1988).
138. Lash LH, Anders MW. Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem 261:13076-13081 (1986).
139. 1 cells. J Biol Chem 261:3325-3332 (1986).
140. Wolfgang GHI, Gandolfi AJ, Nagle RB, Brendel K, Stevens JL. Assessment of S-(1,2-dichlorovinyl)-L-cysteine induced toxic events in rabbit renal cortical slices. Biochemical and histological evaluation of uptake, covalent binding, and toxicity. Chem-Biol Interact 75:153-170 (1990).
141. Hassall CD, Brendel K, Gandolfi AJ. Regulation of a S(trans-1,2-dichlorovinyl)-L-cysteine-induced renal tubular toxicity by glutathione. J Appl Toxicol 3:321-325 (1983).
142. Groves CE, Hayden PJ, Lock EA, Schnellmann RG. Differential cellular effects in the toxicity of haloalkene and tialoalkane cysteine conjugates to rabbit renal proximal tubules. J Biochem Toxicol 8:49-56 (1993).
143. Lash LH, Nelson RM, Van Dyke RA, Anders MW. Purification and characterization of human kidney cytosolic cysteine conjugate β-lyase activity. Drug Metab Dispos 18:50-54 (1990).
144. Chen JC, Stevens JL, Trifillis AL, Jones TW. Renal cysteine conjugate β-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells. Toxicol Appl Pharmacol 103:463-473 (1990).
145. Cummings BS, Lasb LH. Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol Sci 53:458-466 (2000).
146. Iyer RA, Fook EJ Jr, Ebert TJ, Anders MW. Cysteine conjugate β-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Anesthesiology 88:611-618 (1998).
147. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, Kerschmann RL. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology 80:556-565 (1994).
148. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, kerschmann RL. Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology 80:566-573 (1994).
149. Jin L, Baillie TA, Davis MR, Kharasch ED. Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluomethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate β-lyase. Biochem Biophys Res Commun 210:498-506 (1995).
150. Kandel L, Laster MJ, Eger II EI, Kerschmann RL, Martin J. Nephrotoxicity in rats undergoing a one-lour exposure to compound A. Anesth Analg 81:559-563 (1995).
151. Keller KA, Callan C, Prokocimer P, Delgado-Herrera L, Friedman MB, Hoffman GM, Wooding WL, Cusick PK, Krasula RW. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats. Anesthesiology 83:1220-1232 (1995).
152. Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty GC. Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 86:160-171 (1997).
153. Martin JL, Kandel L, Laster M, Kerschmann RL, Eger EI II. Studies of the mechanism of the nephrotoxicity of compound A in rats. J Anesthesiol 11:32-37 (1997).
154. Morio M, Fujii K, Satoh N, Imai M, Kawakami U, Mizuno T, Kawai Y, Ogasawara Y, Tamura T, Negishi A, Kumazai Y, Kawai T. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology 77:1155-1164 (1992).
155. Jin L, Davis MR, Kharasch ED, Doss GA, Baillie TA. Identification in rat bile of glutathione conjugates of fluoromethyl-2,2-difluoro-1-(trifluomethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Chem Res Toxicol 9:555-561 (1996).
156. Stijntjes GJ, Commandeur JN, te Koppele JM, McGuiness S, Gandolfi AJ, Vermeulen NP. Examination of the structure-toxicity relationships of L-cysteine-S-conjugates of halogenated alkenes and their corresponding mercapturic acids in rat renal tissue slices. Toxicology 79:67-79 (1993).
157. Wolfgang GH, Gandolfi AJ, Stevens JL, Brendel K. N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices: differential transport and metabolism. Toxicol App Pharmacol 101:205-219 (1989).
158. Elfarra AA, Lash LH, Anders MW. α-Ketoacids stimulate rat renal cysteine conjugate β-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine. Mol Pharmacol 31:208-212 (1987).
159. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA. Role of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 269:374-383 (1994).
160. MacFarlane M, Foster JR, Gibson GG, King LJ, Lock EA. Cysteine conjugate β-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicity. Toxicol Appl Pharmacol 98:185-197 (1989).
161. Jones TW, Qin C, Schaeffer VH, Stevens JL. Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate β-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity. Mol Pharmacol 34:621-627 (1988).
162. Lash LH, Elfarra AA, Rakiewicz-Nemeth D, Anders MW. Bioactivation mechanism of cytotoxic homocysteine S-conjugates. Arch Biochem Biophys 276:322-330 (1990).
163. Stevens JL, Hatzinger PB, Hayden PJ. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-α-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate β-lyase. Drug Metab Dispos 17:297-303 (1989).
164. Sausen PJ, Elfarra AA. Reactivity of cysteine S-conjugate sulfoxides: Formation of S-[1-chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem Res Toxicol 4:655-660 (1991).
165. Hashmi M, Vamvakas S, Anders MW. Bioactivation mechanism of S-(3-propyl)-N-acetyl-L-cysteine, the mercapturic acid of acrolein. Chem Res Toxicol 5:360-365 (1992).
166. Park SB, Osterloh JD, Vamvakas S, Hashmi M, Anders MW, Cashman JR. Flavin-containing monooxygenase-dependent stereoselective S-oxygenation and cytotoxicity of cysteine S-conjugates and mercapturates. Chem Res Toxicol 5:193-201 (1992).
167. Werner M, Birner G, Dekant W. Sulfoxidation of mercapturic acids derived from tri-and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate β-lyase mediated cleavage. Chem Res Toxicol 9:41-49 (1996).
168. Sausen PJ, Duescher RJ, Elfarra AA. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol Pharmacol 43:388-396 (1993).
169. Davies KJA. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61:1-31 (1995).
170. Chen Q, Jones TW, Brown PC, Stevens JL. The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells: covalent binding leads to thiol depletion and lipid peroxidation. J Biol Chem 265:21603-21611 (1990).
171. Chen Q, Jones TW, Stevens JL. Early events couple covalent binding of reactive metabolites to cell killing by nephrotoxic cysteine conjugates. J Cell Physiol 161:293-302 (1994).
172. Groves CE, Lock EA, Schnellmann RG. Role of lipid peroxidation in renal proximal tubule cell death induced by haloalkene cysteine conjugates. Toxicol Appl Pharmacol 107:54-62 (1991).
173. Lash LH, Elfarra AA, Anders MW. Renal cysteine conjugate β-lyase: bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. J Biol Chem 261:5930-5935 (1986).
174. Lash LH, Anders MW. Mechanism of S-(1,2-dichlorovinyl)-L-cysteine-and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. Mol Pharmacol 32:549-556 (1987).
175. van de Water B, Zoeteweij JP, de Bont HJGM, Nagelkerke JF. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury. Mol Pharmacol 48:928-937 (1995).
176. Groves CE, Lock EA, Schnellmann RG. The effects of haloalkene cysteine conjugates on cytosolic free calcium levels in suspensions of rat renal proximal tubules. J Biochem Toxicol 5:187-192 (1990).
177. Vamvakas S, Sharma VK, Sheu SS, Anders MW. Perturbations of intracellular calcium distribution in kidney cells by nephrotoxic haloalkenyl cysteine S-conjugates. Mol Pharmaco 38:455-461 (1990).
178. Parker VH. A biochemical study of the toxicity of S-(1,2-dichlorovinyl)-L-cysteine. Food Cosmet Toxicol 3:75-84.
179. Stonard MD, Parker VH. 2-Oxoacid dehydrogenases of rat liver mitochondria as the site of action of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-3-mercaptopropionic acid Biochem Pharmacol 20:2417-2427 (1971).
180. Stonard MD, Parker VH. The metabolism of S-(1,2-dichlorovinyl)-L-cysteine by rat liver mitochondria. Biochem Pharmacol 20:2429-2437 (1971).
181. 2+ in the oxidatve stress-induced dissipation of the mitochondrial membrane potential: studies in isolated proximal tubular cells using the nephrotoxin 1,2-dichlorovinyl-L-cysteine. J Biol Chem 269:14546-14552 (1994).
182. Hayden PJ, Stevens JL. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria. Mol Pharmacol 37:468-476 (1990).
183. 2+ and the mitochondrial membrane potential in isolated proximal tubular cells from rat kidney exposed to the nephrotoxin 1,2-dichlorovinyl-cysteine. Biochem Pharmacol 45:2259-2267 (1993).
184. Hayden PJ, Ichimura T, McCann DJ, Pohl LR, Stevens JL. Detection of cysteine conjugate metabolite adduct formation with specific mitochondrial proteins using antibodies raised against halothane metabolite adducts. J Biol Chem 266:18415-18418 (1991).
185. Hayden PJ, Welsh CJ, Yang Y, Schaefer WH, Ward AJ, Stevens JL. Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolites. Chem Res Toxicol 5:232-237 (1992).
186. Banki K, Anders MW. Inhibition of rat kidney mitochondrial DNA, RNA and protein synthesis by halogenated cysteine S-conjugates. Carcinogenesis 10:767-772 (1989).
187. Eyre RJ, Stevens DK, Parker JC, Bull RJ. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethylene metabolism. J Toxicol Environ Health 46:443-464 (1995).
188. Eyre RJ, Stevens DK, Parker JC, Bull RJ. Renal activation of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine and cell proliferative responses in the kidneys of F344 rats and B6C3F1 mice. J Toxicol Environ Health 46:465-481 (1995).
189. Lock EA, Schnellmann RG. The effect of haloalkene cysteine conjugates on rat renal glutathione reductase and lipoyl dehydrogenase activities. Toxicol Appl Pharmacol 104:180-190 (1990).
190. Chen Q, Yu K, Stevens JL. Regulation of the cellular stress response by reactive electrophiles: the role of covalent binding and cellular thiols in transcriptional activation of the 70-kilodalton heat shock gene by nephrotoxic cysteine conjugates. J Biol Chem 267:24322-24327 (1992).
191. Bruschi SA, West KA, Crabb JW, Gupta RS, Stevens JL. Mitochondrial HSP60 (P1 protein) and HSP70-like protein (mortalin) are major targets for modification during S-(1,1,2,2-tetrafluoroethyl)-L-cysteine-induced nephrotoxicity. J Biol Chem 268:23157-23161 (1993).
192. 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab Invest 66:474-484 (1992).
193. Ward JM, Stevens JL, Konishi N, Kurata Y, Uno H, Diwan BA, Ohmori T. Vimentin metaplasia in renal cortical tubules of pre-neoplastic, neoplastic, aging, and regenerative lesions of rats and humans. Am J Pathol 141:955-964 (1992).
194. Counts RS, Nowak G, Wyatt RD, Schnellmann RG. Nephrotoxicant inhibition of renal proximal tubule cell regeneration. Am J Physiol 269:F274-F281 (1995).
195. Kays SE, Schnellmann RG. Regeneration of renal proximal tubule cells in primary culture following toxicant injury: Response to growth factors. Toxicol Appl Pharmacol 132:273-280 (1995).
196. Kays SE, Berdanier CD, Swagler AR, Lock EA, Schnellmann EA. An in vitro model of renal proximal tubule cell regeneration. J Pharmacol Toxicol Methods 29:211-215 (1993).
197. 1 cells: a comparative investigation with growth factors and 12-O-tetradecanoylphorbolacelate. Cell Biol Toxicol 9:1-13 (1993).
198. 1 cells. J Cell Physiol 161:303-311 (1994).
199. Chen Q, Yu K, Holbrook NJ, Stevens JL. Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and cithiothreitol. J Biol Chem 267:8207-8212 (1992).
200. van Welie RT, van Dijck RG, Vermeulen NP, van Sittert NJ. Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. CRC Crit Rev Toxicol 22:271-306 (1992).
201. Lash LH, Lipscomb JC, Futt DA, Parker JC. Glutathione conjugation of trichloroethylene in human liver and kidney kinetics and individual variation. Drug Metab Dispos 27:351-350 (1999).
202. Lash LH, Putt DA, Brashear WT, Abbas R, Parker JC, Fisher JW. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J Toxicol Environ Health 56:1-21 (1999).
203. Völkel W, Friedewald M, Lederer E, Pähler A, Parker J, Dekant W. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. Toxicol Appl Pharmacol 153:20-27 (1998).
204. Kharasch ED, Jubert C, Spracklin DK, Hoffman GM. Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), an anesthetic degradation product, to mercapturic acids and 3,3,3-trifluoro-2-(fluoromethoxy)propanoic acid in rats. Toxicol Appl Pharmacol 160:49-59 (1999).
205. Kharasch ED, Jubert C. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison. Anesthesiology 91:1267-1278 (1999).
206. Cummings BS, Parker JC, Lash LH. Role of cytochrome P450 and glutathione S-transferase α in the metabolism and cytotoxicity of trichloroethylene in rat kidney. Biochem Pharmacol (in press).
207. Cummings BS, Lasker JM, Lash LH. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly-isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther (in press).
208. Green T, Dow J, Ellis MK, Foster JR, Odum J. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem-Biol Interact 105:99-117 (1997).
209. Pähler A, Parker J, Dekant W. Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation. Toxicol Sci 48:5-13 (1999).